Long lasting response with trabectedin monotherapy in relapsed metastatic mesenchymal chondrosarcoma

BACKGROUND: Mesenchymal chondrosarcoma is an exceedingly rare malignancy, accounting for around 5% of all patients with chondrosarcoma. It is a translocation-related sarcoma that tends to have both local and distant recurrences. Surgery is the mainstay of treatment in localised cases however treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Tansir, Ghazal, Rastogi, Sameer, Barwad, Adarsh, Dhamija, Ekta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453529/
https://www.ncbi.nlm.nih.gov/pubmed/32864096
http://dx.doi.org/10.1186/s13569-020-00138-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453529/
https://www.ncbi.nlm.nih.gov/pubmed/32864096
http://dx.doi.org/10.1186/s13569-020-00138-4

Ejemplares similares